Surgery Partners, Inc. declines Bain Capital's $25.75/share offer, citing growth potential. Click for my updated look at SGRY ...

A recent Bloomberg report said the deal is worth nearly $4 billion. Not happening, however, is Bain Capital buying all of ...

Two major deals on June 17 are poised to reshape the competitive landscape of ASCs: Ascension’s definitive agreement to acquire AmSurg, and Surgery Partners’ rejection of a buyout bid from Bain ...

Recent news in the health sector includes Surgery Partners' rejection of Bain Capital's take-private offer, Purdue Pharma's ...

Recent health headlines spotlight Surgery Partners rejecting Bain Capital's offer, the U.S. betting on China's drug potential ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Surgery Partners rejects Bain Capital's offer, choosing to stay public. Here's why the local company said no and the future ...

Brentwood, Tenn.-based Surgery Partners has rejected a proposal from private equity firm Bain Capital to acquire all outstanding shares not already owned by the firm, reaffirming its commitment to ...

Surgery Partners said on Tuesday it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take ...

Surgery Partners rejects Bain Capital's acquisition bid, citing greater long-term value as a public company with strong ...

Surgery Partners (NASDAQ:SGRY) shares fell on Tuesday after the healthcare facilities operator rejected Bain Capital's ...